Return to Statistics Toolbox

OPLS-DA analysis for Study ST000196

(Analysis AN000298 )

Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Recovery:five week recovery | Gender:female | Treatment:Cefoperazone treated
Recovery:five week recovery | Gender:male | Treatment:Cefoperazone treated
Recovery:four week recovery | Gender:female | Treatment:Cefoperazone treated
Recovery:four week recovery | Gender:male | Treatment:Cefoperazone treated
Recovery:na | Gender:female | Treatment:No antibiotics
Recovery:na | Gender:male | Treatment:No antibiotics
Recovery:no recovery | Gender:female | Treatment:Cefoperazone treated
Recovery:no recovery | Gender:female | Treatment:IP clindamycin
Recovery:no recovery | Gender:female | Treatment:Kanamycin treated
Recovery:no recovery | Gender:female | Treatment:Metronidazole treated
Recovery:no recovery | Gender:female | Treatment:Vancomycin treated
Recovery:no recovery | Gender:male | Treatment:Cefoperazone treated
Recovery:no recovery | Gender:male | Treatment:IP clindamycin
Recovery:no recovery | Gender:male | Treatment:Kanamycin treated
Recovery:no recovery | Gender:male | Treatment:Metronidazole treated
Recovery:no recovery | Gender:male | Treatment:Vancomycin treated
Recovery:one week recovery | Gender:female | Treatment:Cefoperazone treated
Recovery:one week recovery | Gender:male | Treatment:Cefoperazone treated
Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated
Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated IP clindamycin
Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated
Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated IP clindamycin
Recovery:three week recovery | Gender:female | Treatment:Cefoperazone treated
Recovery:three week recovery | Gender:male | Treatment:Cefoperazone treated
Recovery:two week recovery | Gender:female | Treatment:Cefoperazone treated
Recovery:two week recovery | Gender:male | Treatment:Cefoperazone treated

  logo